BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Behrooz AB, Syahir A. Could We Address the Interplay Between CD133, Wnt/β-Catenin, and TERT Signaling Pathways as a Potential Target for Glioblastoma Therapy? Front Oncol 2021;11:642719. [PMID: 33869033 DOI: 10.3389/fonc.2021.642719] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Kim CW, Lee HK, Nam MW, Lee G, Choi KC. The role of KiSS1 gene on the growth and migration of prostate cancer and the underlying molecular mechanisms. Life Sci 2022;:121009. [PMID: 36181862 DOI: 10.1016/j.lfs.2022.121009] [Reference Citation Analysis]
2 Nayak C, Singh SK. Integrated Transcriptome Profiling Identifies Prognostic Hub Genes as Therapeutic Targets of Glioblastoma: Evidenced by Bioinformatics Analysis. ACS Omega. [DOI: 10.1021/acsomega.2c01820] [Reference Citation Analysis]
3 Smiley SB, Zarrinmayeh H, Das SK, Pollok KE, Vannier MW, Veronesi MC. Novel therapeutics and drug-delivery approaches in the modulation of glioblastoma stem cell resistance. Ther Deliv 2022. [PMID: 35615860 DOI: 10.4155/tde-2021-0086] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Daisy Precilla S, Biswas I, Kuduvalli SS, Anitha TS. Crosstalk between PI3K/AKT/mTOR and WNT/β-Catenin signaling in GBM - Could combination therapy checkmate the collusion? Cell Signal 2022;:110350. [PMID: 35525406 DOI: 10.1016/j.cellsig.2022.110350] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Abdoli Shadbad M, Hosseinkhani N, Asadzadeh Z, Brunetti O, Silvestris N, Baradaran B. The Prognostic Value of CD133 in Predicting the Relapse and Recurrence Pattern of High-Grade Gliomas on MRI: A Meta-Analysis. Front Oncol 2021;11:722833. [PMID: 34540691 DOI: 10.3389/fonc.2021.722833] [Cited by in F6Publishing: 1] [Reference Citation Analysis]